Navigation Links
High Unemployment Rates in North Carolina Will Continue to Dictate the Decrease of Commercial Health Plan Enrollment and the Increase of Medicaid Enrollment

NASHVILLE, Tenn., Oct. 28 /PRNewswire/ -- HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that high unemployment rates in North Carolina will continue to dictate decreasing commercial health plan enrollment rates and rising Medicaid enrollment rates. However, according to the Carolinas Health Plan Analysis, there is less state funding available to deal with increasing Medicaid enrollment.

The report finds that in order to compensate for this, the state is putting cost-saving measures in place. North Carolina has moved to decrease its drug spending by utilizing a preferred drug list, which will confine drug choices to clinically effective generics and lower-cost alternatives whenever possible. Branded drugs will only be available to recipients on a prior-approval basis. In addition, state legislators have agreed to allow the North Carolina Department of Health and Human Services to enter a multistate purchasing pool to leverage drug rebates and discounts from pharmaceutical companies.

"Compared to other states, North Carolina is late to the table with a preferred drug list," states Jan Shuxteau, market analyst with HealthLeaders-InterStudy. "Pharmaceutical companies will face barriers in the state with prior authorizations and an emphasis on generics. In addition, expect the Department of Health and Human Services to negotiate directly with pharma companies and contract with a pharmacy benefit manager for negotiated discounts and rebates."

Other topics highlighted in the recent Carolinas Health Plan Analysis include:

  • How South Carolina is responding to its increasing Medicaid enrollment.
  • Blue Cross and Blue Shield of North Carolina, the largest plan in the state, and its plan to cut administrative costs by 20 percent.
  • The move by Humana to add the Carolinas HealthCare System to its provider network.

  • Why Pharmaceutical Company Managed Markets Teams Need Health Plan AnalysisHealth Plan Analysis identifies key health plan trends, allowing pharmaceutical companies to create comprehensive strategic plans and sales strategies at state and local levels. Updated quarterly, Health Plan Analysis provides a detailed look at plan design and financials, as well as information about mergers, legislation and other influencers driving healthcare in a particular region.

    About HealthLeaders-InterStudy HealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit

    About Decision Resources, Inc. Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at .

    All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact: Erin O'Leary

    Elizabeth Marshall HealthLeaders-InterStudy

    Decision Resources, Inc. 781-993-2641


    SOURCE HealthLeaders-InterStudy
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Unemployment, Health Care Spending Affect Mortality
    2. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
    3. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
    4. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
    5. GlaxoSmithKline Accelerates Review of Exelixis XL880
    6. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
    7. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
    8. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
    9. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
    10. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
    11. Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label
    Post Your Comments:
    (Date:11/25/2015)... , Nov. 25, 2015  Linden Care, LLC, a ... treatment outcomes for patients suffering from chronic pain, said ... a Temporary Restraining Order (TRO) enjoining Express Scripts from ... companies. --> --> ... of its legal options. --> ...
    (Date:11/25/2015)... AVIV, Israel , November 25, 2015 ... (NASDAQ: KTOV ) (TASE: KTOV), a biopharmaceutical company ... simultaneous treatment of various clinical conditions, today announced the ... 3,158,900 American Depository Shares ( ADSs ), each representing ... purchase up to 3,158,900 ADSs. The ADSs and warrants ...
    (Date:11/25/2015)... , Nov. 25, 2015 Endo International plc (NASDAQ: ... De Silva , President and CEO, will discuss corporate updates ... in New York on Wednesday, December ... . Click on Investor Relations, and then the link to ... the presentation,s start time to visit the site and download ...
    Breaking Medicine Technology:
    (Date:11/25/2015)... ... November 25, 2015 , ... The ... perfect dish and pleasing the palates of attendees is of the utmost importance. ... to a seasonal get-together, give these recipes a try this holiday season. , ...
    (Date:11/25/2015)... Nairobi (PRWEB) , ... November 26, 2015 , ... ... African Union Commission (AUC), European Union (EU), ANDI Pan African Centres of Excellence, ... Nations Office in Nairobi (UNON) for the opening of the 5th African Network ...
    (Date:11/25/2015)... ... November 25, 2015 , ... Dental professionals who would like ... , are invited to attend Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. ... OH. , As the co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli and ...
    (Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Smiles ... of TMJ Disorder, Bruxism, and moderate facial wrinkling. While many patients are aware of ... of the great success Botox® delivers to those suffering with discomfort, soreness, and pain ...
    (Date:11/25/2015)... ... , ... “While riding the bus, I saw a passenger in a wheelchair ... to be a convenient and comfortable way to protect them from bad weather, so ... safely travel during cold or inclement weather. In doing so, it ensures that the ...
    Breaking Medicine News(10 mins):